These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 17619376

  • 1. [A new drug for macular degeneration. A breakthrough accomplished (interview by Waldtraud Paukstadt)].
    Holz FG.
    MMW Fortschr Med; 2007 Jan 18; 149(3):13-4. PubMed ID: 17619376
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bevacizumab and ranibizumab. Bevacizumab and the inverse postcode lottery.
    Harris MJ.
    BMJ; 2010 Jul 13; 341():c3718. PubMed ID: 20627986
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of neovascular age-related macular degeneration: an unresolved matter].
    Flores-Moreno S, Bautista-Paloma J.
    Arch Soc Esp Oftalmol; 2008 Jul 13; 83(7):405-6. PubMed ID: 18592439
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Wiwanitkit V.
    Graefes Arch Clin Exp Ophthalmol; 2010 Nov 13; 248(11):1675; author reply 1677. PubMed ID: 20424851
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Should Avastin be used to treat age-related macular degeneration in the NHS?--Yes.
    Raftery J, Dent L.
    Eye (Lond); 2009 Jun 13; 23(6):1247-9. PubMed ID: 19407834
    [No Abstract] [Full Text] [Related]

  • 12. [VEGF inhibitors in ophthalmology].
    Thys J, Dupont G, Rakic JM.
    Rev Med Liege; 2009 Jun 13; 64(5-6):323-6. PubMed ID: 19642468
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Costs of treatment for age-related macular degeneration.
    Gerson JD.
    Optometry; 2009 Jul 13; 80(7):339. PubMed ID: 19753688
    [No Abstract] [Full Text] [Related]

  • 17. Antiangiogenic therapy in neovascular age-related macular degeneration.
    Lin RC, Rosenfeld PJ.
    Int Ophthalmol Clin; 2007 Jul 13; 47(1):117-37. PubMed ID: 17237677
    [No Abstract] [Full Text] [Related]

  • 18. [The current state and issues of medical treatment for age-related macular degeneration].
    Ishida S.
    Nihon Yakurigaku Zasshi; 2008 Jan 13; 131(1):47-9. PubMed ID: 18187884
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.